AriClot™ Hemostatic Powder

AriClot Hemostatic Powder, a flagship product of the knowledge-based company Healda, is engineered as a third-generation topical hemostat based on micro-porous plant polysaccharides (MPH). Its mechanism relies on rapid blood dehydration technology: on contact with blood, the powder particles instantly absorb the liquid phase (plasma) and concentrate a bed rich in platelets, fibrin and clotting factors. The result is a robust gelatinous barrier that physically seals the bleeding path while accelerating the physiological coagulation cascade.

Because the material is non-protein based and highly biocompatible, it provokes no inflammatory reaction or granuloma in host tissue. The ergonomic single-use AriClot applicator lets the surgeon deliver powder precisely, even into deep pockets that are hard to reach in open and laparoscopic procedures. AriClot contains no chemical cross-linkers; once hemostasis is achieved it is broken down by the body's amylase enzymes and cleared completely, which sharply reduces the risk of post-operative infection.